Top venture capital most active in E-Health

30/08/2016
Diego Gutiérrez
Top venture capital most active in E-Health
We have recently learned that Apple has bought Glimpse, a personal health data platform with which users or patients can collect, personalise and share an image of their health data. This company was founded in 2012 and in 2014 received an investment round of 800,000$ in which GV, Matt Monahan and Sherpa Capital participated and which was necessary to give it the necessary liquidity to be able to develop its product.
Do you think your company would also need venture capital? Here are the 3 most active investors since 2014.

List of most active investors since 2014

 

Rock Health

 Founded in 2010, it is a venture capital firm focused on early-stage digital health investments.

Investments are typically in the region of 250K, as well as providing strategic and operational support and access to partners, medical academies and medical centres.

Among its latest investments is Elemental Machine, a company that helps accelerate scientific discovery through cloud-based software and machine learning. The company enables the collection and visualisation of critical data about the physical environment that can influence its experiments.

Although this venture capital is mainly focused on early stage companies, it has also participated in more advanced rounds such as $48M closed in 2015 in the company Omada Healtha company that develops web technology for the health sector.

 

Khosla Ventures

 Unlike Rock Health, Khosla Ventures is not only focused on e-health investments. Khosla invests in technology companies in different fields: environment, ICT, health, mobility...

One niche in which Khosla has been very active has been in the internet of things applied to healthcare. Among the companies in this area in which Khosla has invested are: AstroPrint,Biobots,BioFab, CreoPop, Grom, MarketBot, Pinshape.

In addition, Khosla has previously invested in Spain in other sectors such as mobility.

Qualcomm Ventures

 Founded in 2000, it has made more than 232 investments in technology companies in various sectors.

Last year Novartis launched a fund together with Qualcomm Ventures, to drive new technologies in the digital domain with the potential to change medical practice and improve patients' lives.

Among the companies in which Qualcomm has invested are: Common Sensing, a device to help diabetics manage their disease, and Welltok, which offers users personalised information and incentives to improve their health and habits.

Other posts that may interest you

Investment activity "IOT wearables" for clinical efficiency

Innovation in Iot applied to health

Artificial intelligence in the E-health sector

 

Lastest news

Baker Tilly advises T2O on its acquisition of Fly Me to the Moon

t2ó ONE, una agencia española especializada en performance marketing y transformación digital, ha anunciado la adquisición de Fly Me to the Moon, una agencia creativa reconocida por su enfoque estratégico e innovador. Esta operación permite a t2ó ampliar sus...

Informe de valoración de sector SaaS 2025

Valoración de SaaS en 2025: perspectivas de los mercados públicos El sector SaaS en 2025 presenta un panorama de valoración más realista, aunque cautelosamente optimista. Tras los espectaculares máximos de 2021 y la fuerte corrección de 2022, las valoraciones de las...

How is technology transforming film and television? | 5 trends

El sector audiovisual está viviendo una revolución silenciosa pero imparable. No se trata solo de efectos especiales más espectaculares o de nuevas plataformas de streaming. Estamos asistiendo a una transformación radical en la forma en que se produce, se distribuye y...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

    On which topic would you like to receive information?

    Request for information

    If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

    Or if you prefer, call us at:

    +34 946 42 41 42